NKTR
Nektar Therapeutics
43.60$
-7.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -486.1% | – | – | – | – | – | – | – | – | – | -199.6% | – | -240.6% | – | – | – | – | – | – | – | – | -145.8% | – | – | – | – | – | – | |
| – | +103.2% | +47.6% | +101.6% | +39.6% | +298.9% | -53.0% | -2.9% | +4.2% | +36.7% | +24.4% | -13.7% | -20.1% | -33.8% | +11.2% | -9.7% | -3.0% | -1.6% | -9.4% | -0.6% | +19.4% | -4.0% | -26.3% | +21.0% | +7.8% | -0.3% | -7.9% | -40.0% | -43.8% | -202.2% | |
| – | – | – | – | – | +1.8% | -37.7% | -63.4% | +485.1% | +57.7% | -99.5% | +152,260.8% | -33.2% | +4.6% | +68.5% | +8.5% | -14.2% | +9.3% | -3.9% | +15.6% | +31.4% | +41.6% | +140.6% | +13.3% | -5.5% | +0.4% | -39.5% | -41.8% | -35.3% | -41.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +28.4% | -28.3% | -17.3% | +13.2% | -24.2% | +82.1% | +215.7% | +16.5% | -14.2% | +58.1% | -57.8% | – | – | – | |
| – | +325.9% | -139.8% | – | -30.0% | +122.0% | +30.2% | -278.4% | – | – | -294.0% | – | -125.1% | – | -154.9% | – | – | +5,540.4% | -228.5% | – | – | -574.4% | – | – | -22.9% | -238.1% | – | -4,124.4% | – | – | |
| – | +684.6% | +100.4% | -40.7% | +162.7% | -36.3% | -52.4% | +14.8% | +45.1% | -34.0% | +25.4% | +45.6% | -42.5% | +9.8% | +52.0% | -69.1% | +8.9% | -61.3% | +143.9% | +12.2% | -42.9% | +51.4% | +47.2% | +84.6% | -72.4% | +106.5% | -62.1% | -84.8% | +69.7% | -88.4% | |
| – | +2,129.3% | -92.3% | +1,168.3% | +263.6% | -74.3% | – | -89.9% | -2,283.4% | – | -460.7% | -72.1% | – | -154.3% | – | -769.8% | – | -55.8% | -175.3% | -61.8% | +474.8% | -65.0% | +4,689.9% | – | +139.8% | -59.1% | +80.4% | -61.9% | +2.2% | -100.8% | |
| – | – | – | – | – | – | – | – | – | -80.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -3.6% | – | – | – | – | – | – | -98.2% | +99.4% | +1,892.2% | -80.3% | +550.7% | -71.6% | +1,331.3% | -97.3% | +0.2% | +42.1% | – | – | – | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +4,799.1% | -96.9% | +18.2% | – | -106.0% | -13.7% | +4,772.3% | +0.0% | +0.0% | -100.0% | – | – | – | – | |
| – | +211.9% | -52.0% | +190.9% | +312.2% | -94.8% | +71.2% | +161.6% | +104.8% | +32.5% | -95.7% | -964.6% | -51.1% | – | +113.2% | +2,850.7% | -87.9% | -91.7% | +6,803.6% | -14.5% | +55.7% | -73.3% | +1,466.4% | -97.3% | -444.1% | – | -95.8% | -98.0% | +140,293.3% | +328.7% | |
| – | -124.5% | – | -21.3% | +1,104.9% | -202.6% | – | +617.6% | +38.4% | +467.9% | -186.2% | – | +532.7% | -233.7% | – | – | – | +34.6% | -295.9% | – | -90.6% | -1,448.4% | – | -151.8% | – | -269.3% | – | -184.0% | – | -424.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -245.0% | – | -558.7% | – | – | – | – | – | – | – | – | -150.4% | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.